Skip to main content
Fig. 4 | Radiation Oncology

Fig. 4

From: Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma

Fig. 4

Kaplan–Meier curves according to age, applied therapy, and tumor stages categories for the whole study population showing AB overall survival (p = 0.020 for all) and progression-free survival (p = 0.006 for all) of patients received RT alone and aged 65–74 years in different tumor stages; CD overall survival (p = 0.083 for all) and progression-free survival (p = 0.167 for all) of patients received CRT and aged 65–74 years in different tumor stages; EF overall survival (p = 0.063 for all) and progression-free survival (p = 0. 025 for all) of patients received RT alone and aged 75 years or older in different tumor stages; GH overall survival (p = 0.284 for all) and progression-free survival (p = 0. 241 for all) of patients received CRT and aged 75 years or older in different tumor stages. RT, radiotherapy; CRT, chemoradiotherapy

Back to article page